NEW YORK, June 5 (GenomeWeb News) - ProMetic Life Sciences will raise C$10.8 million, or $9.8 million, through a private placement of 29.6 million subordinate voting shares, the company said on Friday.

 

The private placement will be with JPMorgan and Third Point.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.